These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 23143308)

  • 21. FOXA2 Cooperates with Mutant KRAS to Drive Invasive Mucinous Adenocarcinoma of the Lung.
    Tomoshige K; Stuart WD; Fink-Baldauf IM; Ito M; Tsuchiya T; Nagayasu T; Yamatsuji T; Okada M; Fukazawa T; Guo M; Maeda Y
    Cancer Res; 2023 May; 83(9):1443-1458. PubMed ID: 37067057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-wide analyses of Nkx2-1 binding to transcriptional target genes uncover novel regulatory patterns conserved in lung development and tumors.
    Tagne JB; Gupta S; Gower AC; Shen SS; Varma S; Lakshminarayanan M; Cao Y; Spira A; Volkert TL; Ramirez MI
    PLoS One; 2012; 7(1):e29907. PubMed ID: 22242187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. REG4 is an indicator for KRAS mutant lung adenocarcinoma with TTF-1 low expression.
    Sun S; Hu Z; Huang S; Ye X; Wang J; Chang J; Wu X; Wang Q; Zhang L; Hu X; Yu H
    J Cancer Res Clin Oncol; 2019 Sep; 145(9):2273-2283. PubMed ID: 31428934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occludin is a direct target of thyroid transcription factor-1 (TTF-1/NKX2-1).
    Runkle EA; Rice SJ; Qi J; Masser D; Antonetti DA; Winslow MM; Mu D
    J Biol Chem; 2012 Aug; 287(34):28790-801. PubMed ID: 22761434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An EGFR ligand promotes EGFR-mutant but not KRAS-mutant lung cancer in vivo.
    Tomoshige K; Guo M; Tsuchiya T; Fukazawa T; Fink-Baldauf IM; Stuart WD; Naomoto Y; Nagayasu T; Maeda Y
    Oncogene; 2018 Jul; 37(28):3894-3908. PubMed ID: 29662194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mutational landscapes of genetic and chemical models of Kras-driven lung cancer.
    Westcott PM; Halliwill KD; To MD; Rashid M; Rust AG; Keane TM; Delrosario R; Jen KY; Gurley KE; Kemp CJ; Fredlund E; Quigley DA; Adams DJ; Balmain A
    Nature; 2015 Jan; 517(7535):489-92. PubMed ID: 25363767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of tumorigenic cells in Kras(G12D)-induced lung adenocarcinoma.
    Cho HC; Lai CY; Shao LE; Yu J
    Cancer Res; 2011 Dec; 71(23):7250-8. PubMed ID: 22088965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naproxen inhibits spontaneous lung adenocarcinoma formation in Kras
    Kumar G; Madka V; Singh A; Farooqui M; Stratton N; Lightfoot S; Mohammed A; Rao CV
    Neoplasia; 2021 Jun; 23(6):574-583. PubMed ID: 34091121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffuse expression of MUC6 defines a distinct clinicopathological subset of pulmonary invasive mucinous adenocarcinoma.
    Kishikawa S; Hayashi T; Saito T; Takamochi K; Kohsaka S; Sano K; Sasahara N; Sasa K; Kurihara T; Hara K; Suehara Y; Takahashi F; Suzuki K; Yao T
    Mod Pathol; 2021 Apr; 34(4):786-797. PubMed ID: 33024306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PIK3CA(H1047R) Accelerates and Enhances KRAS(G12D)-Driven Lung Tumorigenesis.
    Green S; Trejo CL; McMahon M
    Cancer Res; 2015 Dec; 75(24):5378-91. PubMed ID: 26567140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of p53 attenuates the contribution of IL-6 deletion on suppressed tumor progression and extended survival in Kras-driven murine lung cancer.
    Tan X; Carretero J; Chen Z; Zhang J; Wang Y; Chen J; Li X; Ye H; Tang C; Cheng X; Hou N; Yang X; Wong KK
    PLoS One; 2013; 8(11):e80885. PubMed ID: 24260500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinoma.
    McFadden DG; Politi K; Bhutkar A; Chen FK; Song X; Pirun M; Santiago PM; Kim-Kiselak C; Platt JT; Lee E; Hodges E; Rosebrock AP; Bronson RT; Socci ND; Hannon GJ; Jacks T; Varmus H
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6409-E6417. PubMed ID: 27702896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MEK1/2 inhibition elicits regression of autochthonous lung tumors induced by KRASG12D or BRAFV600E.
    Trejo CL; Juan J; Vicent S; Sweet-Cordero A; McMahon M
    Cancer Res; 2012 Jun; 72(12):3048-59. PubMed ID: 22511580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-canonical genomic driver mutations of urethane carcinogenesis.
    Li S; Counter CM
    PLoS One; 2022; 17(4):e0267147. PubMed ID: 35482806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPRi-mediated functional analysis of NKX2-1-binding sites in the lung.
    Stuart WD; Fink-Baldauf IM; Tomoshige K; Guo M; Maeda Y
    Commun Biol; 2021 May; 4(1):568. PubMed ID: 33980985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SETDB1 Inhibits p53-Mediated Apoptosis and Is Required for Formation of Pancreatic Ductal Adenocarcinomas in Mice.
    Ogawa S; Fukuda A; Matsumoto Y; Hanyu Y; Sono M; Fukunaga Y; Masuda T; Araki O; Nagao M; Yoshikawa T; Goto N; Hiramatsu Y; Tsuda M; Maruno T; Nakanishi Y; Hussein MS; Tsuruyama T; Takaori K; Uemoto S; Seno H
    Gastroenterology; 2020 Aug; 159(2):682-696.e13. PubMed ID: 32360551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NKX2-1/TTF-1: an enigmatic oncogene that functions as a double-edged sword for cancer cell survival and progression.
    Yamaguchi T; Hosono Y; Yanagisawa K; Takahashi T
    Cancer Cell; 2013 Jun; 23(6):718-23. PubMed ID: 23763999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NOS2 enhances KRAS-induced lung carcinogenesis, inflammation and microRNA-21 expression.
    Okayama H; Saito M; Oue N; Weiss JM; Stauffer J; Takenoshita S; Wiltrout RH; Hussain SP; Harris CC
    Int J Cancer; 2013 Jan; 132(1):9-18. PubMed ID: 22618808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of a highly sensitive lung cancer compact panel to detect KRAS G12D in the wash fluid from a lung tumor: A case report.
    Minami D; Takigawa N; Nakajima Y; Miyahara N; Mizumori Y; Ueda M; Nakamura S; Suzuki F; Sato Y; Morikawa K; Kanehiro A
    Thorac Cancer; 2022 Jun; 13(11):1735-1738. PubMed ID: 35545933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mouse model of proximal colon-specific tumorigenesis driven by microsatellite instability-induced Cre-mediated inactivation of Apc and activation of Kras.
    Kawaguchi Y; Hinoi T; Saito Y; Adachi T; Miguchi M; Niitsu H; Sasada T; Shimomura M; Egi H; Oka S; Tanaka S; Chayama K; Sentani K; Oue N; Yasui W; Ohdan H
    J Gastroenterol; 2016 May; 51(5):447-57. PubMed ID: 26361962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.